Your medical briefing
Research, guidelines, and safety alerts for your specialty.
Recent updates in Nuclear Medicine from the last 30 days.
Baxter Healthcare Corporation has issued a Class I recall for Dextrose Injection, USP, 70%, in 2000 mL bags (NDC 00338-0719-06). The recall was initiated due to the presence of particulate matter identified as stainless steel particles within the solution, according to the recall notice.
Baxter Healthcare Corporation has issued a Class I recall for 0.9% Sodium Chloride Injection USP, 500 mL VIAFLEX plastic containers (NDC 0338-0049-03), packaged 24 units per case. The recall was initiated due to the presence of particulate matter identified as fiberglass within the product. FDA designates Class I recalls as involving situations where use of the product could cause serious adverse health consequences.
Accord Healthcare, Inc. issued a Class II recall for Levothyroxine Sodium Tablets, USP, 88 mcg, in 1000-count bottles (NDC 16729-450-17), manufactured by Intas Pharmaceuticals Limited. The recall notice cites the product as subpotent.
FDA has classified a Class II recall for Accord Healthcare's Levothyroxine Sodium Tablets, USP, 100 mcg, distributed in 90-count and 1000-count bottles. The recall was issued due to the product being subpotent, according to the FDA notice. The affected lots were manufactured by Intas Pharmaceuticals Limited in India for Accord Healthcare, Inc.
FDA reports a Class II recall of Accord Healthcare Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), distributed in 90-count and 1000-count bottles (NDC 16729-456-15 and 16729-456-17). The recall reason listed is that the product is a subpotent drug. The tablets were manufactured by Intas Pharmaceuticals Limited in India for Accord Healthcare, Inc.
Accord Healthcare, Inc. has issued a Class II recall for Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), in 1000-count bottles, NDC 16729-455-17, manufactured by Intas Pharmaceuticals Limited in India. The recall was classified due to the product being subpotent.
Accord Healthcare, Inc. has issued a Class II recall for Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, NDC 16729-449-17, manufactured by Intas Pharmaceuticals Limited. The recall notice cites the product as a subpotent drug, meaning the tablets contain less active ingredient than labeled.
Accord Healthcare, Inc. issued a Class II recall of Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, NDC 16729-458-15, manufactured by Intas Pharmaceuticals Limited. The recall was classified due to the product being subpotent.
